Open AccessPotential molecular biomarkers used to predict the response to biological therapies in ulcerative colitis
Author(s) -
Runfeng Zhang,
Shuang Liu,
Yunwei Wang,
Ji Li
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001390
Subject(s) - vedolizumab , medicine , calprotectin , ulcerative colitis , ustekinumab , clinical trial , inflammatory bowel disease , disease , ruxolitinib , infliximab , faecal calprotectin , immunology , bone marrow , myelofibrosis